Synapse - Works

Results (1701)

Complexed PSA and free to total PSA ratio provide equivalent specificity in the detection of prostate cancer but would save biopsies in different patient populations

Meeting Abstract

Allard, W. J.; Cheli, C. D.; Neaman, I. E.; Goldblatt, J.; Morris, D. L.; Smith, C.; Schwartz, M. K.; Bruzek, D.; Sokoll, L.; Yeung, K. K.
Clinical Chemistry (1999)

Fulltext@MSK | Save

Novel mathematical approaches for understanding gene expression data and its role in anticancer drug development and target selection

Meeting Abstract

Sharma, S.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

The Hsp90 chaperone system as a potential therapeutic target: Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases

Meeting Abstract

Zheng, F. Z. F.; Münster, P. N.; Kuduk, S.; Danishefsky, S.; Sepp-Lorenzino, L.; Rosen, N.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Induction of differentiation and apoptosis in human breast cancer cell lines by modified geldanamycin derivatives (17-AAG)

Meeting Abstract

Münster, P. N.; Zheng, F. F.; Srethapakdi, M.; Sausville, E.; Rosen, N.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

The cyclin-dependent kinase (CDK) inhibitor flavopiridol (flavo) potentiates radiotherapy (RT) induced apoptosis in association with loss of p21(waf1/cip1)

Meeting Abstract

Jung, C. P.; Motwani, M. V.; Haimovitz-Friedman, A.; Schwartz, G. K.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Phase I trial of sequential paclitaxel and cisplatin in combination with the cyclin dependent kinase inhibitor flavopiridol (flavo) in patients with advanced solid tumors

Meeting Abstract

Schwartz, G. K.; Kaubisch, A.; Saltz, L.; Ilson, D.; O'Reilly, E.; Barazzuol, J.; Endres, S.; Stoltz, M.; Tong, W.; Kelsen, D. P.; more...
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis

Meeting Abstract

Hsueh, C. T.; Kelsen, D. P.; Schwartz, G. K.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

The use of the prostate xenograft CWR22 and its androgen independent sublines in the preclinical development of herceptin

Meeting Abstract

Higgins, B.; Fox, W. D.; Maiese, K.; Fazzari, M.; Scher, H. I.; Agus, D. B.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by co-administration of ZD1839 (Iressa™), an inhibitor of EGF receptor tyrosine kinase

Meeting Abstract

Sirotnak, F. M.; Miller, V. A.; Scher, H. I.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Phase I study of oral ZD1839 (Iressa™), a novel inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR-TK): Evidence of good tolerability and activity

Meeting Abstract

Kris, M.; Ranson, M.; Ferry, D.; Hammond, L.; Averbuch, S.; Ochs, J.; Rowinsky, E.
Clinical Cancer Research (1999)

Fulltext@MSK | Save